Saves the questions and what to expect into your notes, next to the visit they belong to.
Keep this study
Lead
George Washington University
The purpose of this study is to assess whether the DigniCap Scalp Cooling System can help prevent chemotherapy-induced hair loss in Black patients undergoing treatment for breast cancer. The primary objective of this study is to provide a preliminary assessment of the efficacy of the DigniCap Scalp Cooling in Black patients as prevention for chemotherapy induced alopecia.
Age
21–any
Sex
FEMALE
Healthy volunteers
Not accepted
You may be eligible if
Diagnosed with early stage breast cancer (stage I-III)
Self-identify as Black
Planned therapy with taxane and/or anthracycline-based chemotherapy (at least 4 cycles must be planned)
-≥ 21 years of age
Able to give informed consent
You may not be if
Female pattern hair loss or hair loss disorder
Scalp folliculitis
Scalp psoriasis Scalp seborrheic dermatitis
Inflammatory scalp conditions such as lichen planopillaris or alopecia areata
Subjects wearing wigs or subjects who shave their hair prior to chemotherapy
Unable to provide consent or make allotted clinical visits
Subjects with cold agglutinin disease or cold urticaria
Unwilling to remove hair extensions during treatment phase which can interfere with study assessments
